Hormone Therapy

For care with nonbinary children, there are no guidelines, there is very little experience, and all the knowledge we have is anecdotal. There is also not enough research.

In a little more than a decade, access to gender-affirming care for minors has increased greatly across the U.S.

Data on how stigmatization stress responses and gender-affirming hormone therapies may impact the heart health of transgender and gender-diverse individuals are lacking, researchers reported.

Marginalization and stigma are directly related to poor physical and mental health outcomes, according to a speaker at the ACP Internal Medicine Meeting, held virtually.

The FDA approved a combination drospirenone and estetrol tablet for the prevention of pregnancy, the first combination pill containing naturally occurring estrogen, according to an industry press release.

Gender-affirming hormone therapy may cause a decrease in mean systolic BP in transgender women and an increase in mean systolic BP in transgender men, researchers reported.

Transgender adolescents treated with gender-affirming hormone therapy early in puberty experience bone development more similar to that of their experienced gender compared with their gender assigned at birth, according to study data.

Oral testosterone undecanoate is an effective long-term therapy for men with hypogonadism, with a safety profile that is similar to other approved testosterone formulations, data from an extension study show.

Arkansas on Tuesday became the first state to outlaw any gender-affirming medical treatments for minors who may be transgender, overriding a veto from the governor and prompting outcry from providers and advocates.

Gender‐affirming hormone therapy appeared to increase overall procoagulant profiles among transgender women but not transgender men, according to study results published in Journal of Thrombosis and Haemostasis.